🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study, the efficacy and safety of two nilotinib doses, 300 mg twice...
Status
Completed
Location
University of California at Los Angeles Dept. of Hematology Clinic
Start Date
2007-07-31
Trial ID
NCT00471497
The purpose of this study is to determine whether nilotinib is efficacious ...
Status
Completed
Location
City of Hope National Medical Center City of Hope national Med Ctr
Start Date
2010-06
Trial ID
NCT01028222
The goal of this clinical research study is to learn if Tasigna® (nilotinib...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-01
Trial ID
NCT01270893
Treatments Being Tested
In this study, the efficacy of nilotinib at 400 mg BID will be compared wit...
Status
Unknown
Location
Seoul St. Mary's Hospital
Start Date
2009-01
Trial ID
NCT01400074
Treatments Being Tested
The extension study followed the core study CAMN107ECN02 (NCT01275196). whi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-07-17
Trial ID
NCT02272777
A phase IIa open-label single center pilot study to assess the safety and e...
Status
Completed
Location
Hospital for Special Surgery
Start Date
2010-07
Trial ID
NCT01166139
Treatments Being Tested
To evaluate the major molecular response (MMR) rate at 12 months of nilotin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-12
Trial ID
NCT01043874
Treatments Being Tested
"This is a single-arm, open-label, multi-center study of complete molecular...
Status
Completed
Location
Pacific Cancer Medical Center, Inc.
Start Date
2010-11
Trial ID
NCT01227577
Treatments Being Tested
The purpose of this Cohort Treatment Plan is to allow access to Nilotinib f...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04518644
Treatments Being Tested
This study will evaluate the preliminary efficacy of nilotinib in pretreate...
Status
Completed
Location
Novartis Investigative Site
Start Date
2008-11
Trial ID
NCT01289028
Treatments Being Tested